TrialLeukemia & lymphoma2014

Fludarabine, cyclophosphamide and rituximab plus granulocyte macrophage colony-stimulating factor as frontline treatment for patients with chronic lymphocytic leukemia.

Paolo Strati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.